NYSPFP Home
Skip Top Navigation

Adverse Drug Events

Adverse Drug Events

The NYSPFP initiative to reduce Adverse Drug Events (ADE) is designed to work with hospitals to implement standardized best practices around the management of three high-alert medications: insulin, anticoagulants, and opioids. NYSPFP provides hospitals’ multidisciplinary teams with key principles and education on improving high-alert medication safety, best practices for safe opioid prescribing and administration, and enhancing the involvement of the pharmacist in hospital processes.

Goal:
To reduce adverse drug events by 20%.
Approach:
NYSPFP offers a multifaceted approach to improving hospitals’ ADE efforts through collaborations with nationally and internationally recognized organizations in the area of safe medication management and best practices related to opioid stewardship.

In addition to the statewide webinars and regional in-person conferences that are the backbone of our educational outreach, NYSPFP also provides tailored hospital-specific support with on-site and virtual coaching. Through the Rapid-Cycle Improvement Program (RCIP), NYSPFP assists multidisciplinary unit-level teams conduct individualized quality improvement projects in glycemic management and anticoagulation therapy related to VTE prevention.
My ReportsLatest News
This is the latest ADE News
My ReportsUpcoming Events
These are the upcoming ADE Events
My ReportsMy Reports
These are the ADE Reports
 
Persons with disabilities having problems accessing any NYSPFP materials or resources for this initiative may call 518-431-7685 or email Nancy Landor.
Accessibility       Terms & Conditions       Contacts